OTC · Financial Statements

Hypertension Diagnostics, Inc. (HDII) Financial Statements

$0.00 OTC: HDII Market Cap $13681

Hypertension Diagnostics, Inc. most recently reported annual revenue of $0, net profit of $0. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20182019202020212022
Revenue$4.0M$4.0M$0$0$0
Operating Profit$0$0$0$0$0
Net Profit$0$0$3.0M$0$0
EPS$0.00$0.00$0.02$0.00$0.00
Op Margin-11.0%-4.3%———

Balance Sheet (USD)

Metric20182019202020212022
Total Assets$1.0M$1.0M$1.0M$1.0M$0
Total Liabilities$6.0M$6.0M$2.0M$2.0M$0
Cash$0$0$0$0$0
Borrowings$4.0M$5.0M$1.0M$1.0M$0

Cash Flow (USD)

Metric20182019202020212022
Operating Cash Flow$0$0$3.0M$0$-1.0M
Investing Cash Flow$0$0$0$0$1.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$0$0$0$0$0
Free Cash Flow$0$0$3.0M$0$-1.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA0.10
FCF Yield-6521.87%
Quick Ratio0.00
Interest Coverage0.00
Return 1Y0.00%
Return 3Y-95.83%
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Financial Services StocksLow P/E Financial Services StocksHigh Net Margin Financial Services StocksDividend Financial Services StocksLow Debt Financial Services StocksAll stock screens
HDII Overview HDII Dividend Run Stock Screener